中国药业2017，Vol.26Issue(10)：60-62,3.DOI:10.3969/j.issn.1006-4931.2017.10.017
门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死室性心律失常临床研究
Clinical Study of Potassium Magnessium Aspartape Combined with Amiodarone in Treating Ventricular Arrhythmias in Acute Myocardial Infarction
李春杰1
作者信息
- 1. 河南省洛阳市第三人民医院急诊内科,河南洛阳 471002
- 折叠
摘要
Abstract
Objective To analyze the clinical effect of Potassium Magnessium Aspartape combined with Amiodarone in treating ventricu-lar arrhythmias in acute myocardial infarction. Methods Totally 150 patients with ventricular arrhythmias and acute myocardial infarc-tion from February 2010 to April 2016 were randomly divided into two groups,75 cases in each group. The control group was given Amiodarone,while the observation group was given Potassium Magnessium Aspartape combined with Amiodarone. The clinical efficacy, ECG,laboratory parameters and adverse reactions were compared between the two groups. Results The total effective rate and the inci-dence rate of adverse reactions in the observation group were 93. 33% and 6. 67%,which had significantly difference with 81. 33%and 21. 33% in the control group (P < 0. 05). After treatment,the twelve lead ECG and laboratory indexes of the two groups had sig-nificant differences (P < 0. 05). Conclusion Potassium Magnessium Aspartape combined with Amiodarone in treating ventricular ar-rhythmias in acute myocardial infarction has significant effect with less adverse reactions,it is worthy of clinical promotion.关键词
急性心肌梗死/胺碘酮/门冬氨酸钾镁/室性心律失常/临床疗效Key words
acute myocardial infarction/Amiodarone/Potassium Magnessium Aspartape/ventricular arrhythmias/clinical effect分类
医药卫生引用本文复制引用
李春杰..门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死室性心律失常临床研究[J].中国药业,2017,26(10):60-62,3.
